1. Sarkar PS, Paul S, Han J, Reddy S. Six5 is required for spermatogenic cell survival and spermiogenesis. Hum Mol Genet. 2004. 13:1421–1431.
2. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science. 1992. 255:1253–1255.
3. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell. 1992. 68:799–808.
4. Klesert TR, Otten AD, Bird TD, Tapscott SJ. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat Genet. 1997. 16:402–406.
5. Kolettis PN. Genetic disease in adults. Urol Clin North Am. 2003. 30:153–160.
6. Brewster B, Groenen P, Wieringa B. Emery AEH, editor. Myotonic dystrophy: clinical and molecular aspects. Neuromuscular disorders: clinical and molecular genetics. 1998. Chichester: John Wiley & Sons Ltd;323–364.
7. Davies J, Yamagata H, Shelbourne P, Buxton J, Ogihara T, Nokelainen P, et al. Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations. J Med Genet. 1992. 29:766–769.
8. Mifsud A, Sim CK, Boettger-Tong H, Moreira S, Lamb DJ, Lipshultz LI, et al. Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility. Fertil Steril. 2001. 75:275–281.
9. Pan H, Li YY, Li TC, Tsai WT, Li SY, Hsiao KM. Increased (CTG/CAG)(n) lengths in myotonic dystrophy type 1 and Machado-Joseph disease genes in idiopathic azoospermia patients. Hum Reprod. 2002. 17:1578–1583.